Dextera Surgical Inc. (NASDAQ:DXTR)’s share price traded up 9.3% on Wednesday . The stock traded as high as $0.24 and last traded at $0.24. 3,900,686 shares were traded during trading, a decline of 1% from the average session volume of 3,931,480 shares. The stock had previously closed at $0.22.

Several equities analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Dextera Surgical from a “strong sell” rating to a “hold” rating in a report on Tuesday. Ladenburg Thalmann Financial Services began coverage on shares of Dextera Surgical in a research note on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target on the stock. Finally, Wedbush decreased their price target on shares of Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a research note on Wednesday, July 12th.

Dextera Surgical (NASDAQ:DXTR) last posted its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.29). The business had revenue of $1.05 million during the quarter, compared to analysts’ expectations of $1.03 million.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Perkins Capital Management Inc. acquired a new stake in Dextera Surgical during the 2nd quarter worth about $100,000. Virtu KCG Holdings LLC raised its holdings in Dextera Surgical by 1,380.6% during the 2nd quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock worth $111,000 after buying an additional 344,933 shares during the period. Finally, Broadfin Capital LLC raised its holdings in Dextera Surgical by 64.7% during the 2nd quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock worth $296,000 after buying an additional 388,080 shares during the period. Hedge funds and other institutional investors own 6.58% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Dextera Surgical Inc. (DXTR) Trading 9.3% Higher” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/10/13/dextera-surgical-inc-dxtr-trading-9-3-higher.html.

About Dextera Surgical

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Receive News & Stock Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related stocks with our FREE daily email newsletter.